Thomas K. Equels, CEO, President at HEMISPHERX BIOPHARMA INC (HEB), bought 115,000 shares at $0.12 ($14K) on 2016-06-30, disclosed to the SEC on 2016-07-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.12 | 29,000 | $3K | 25.2% |
| 2 | $0.12 | 30,000 | $4K | 26.1% |
| 3 | $0.12 | 28,000 | $3K | 24.3% |
| 4 | $0.12 | 28,000 | $3K | 24.3% |
| Total | $0.12 avg | 115,000 | $14K | 100% |
| Filing → |
| AIM | BUY | 2020-12-17 | $25K | — | Filing → |
| AIM | BUY | 2020-09-03 | $25K | — | Filing → |
| AIM | BUY | 2020-08-21 | $25K | — | Filing → |